ELIZABETH SERMONS: Open Payments
NPI 1841667862 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 51 payments from 26 companies in 2025. Trend: 2023 $2,057 · 2024 $3,173 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| PFIZER INC. | 3 | $69 |
| Daiichi Sankyo Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $64 |
| Incyte Corporation | 3 | $60 |
| Exelixis Inc. | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $49 |
Products named: REBLOZYL, LYNPARZA, ENHERTU, CABOMETYX, Fabhalta, KEYTRUDA, BRAFTOVI, Vonjo.
Industry payments across AZ — which companies pay providers there.
